Bicycle Therapeutics has appointed a Chief Medical Officer.  Dr. Dominic Smethurst has joined the Cambridge company, which is developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics.  Dr. Smethurst brings extensive expertise in developing bispecific immuno-oncology agents, as well as toxin conjugate therapeutics for cancer and other serious … Continue reading BioTech Bicycle Therapeutics appoints Chief Medical Officer